Drugs / IL-7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00105417 | Mar 2005 → May 2006 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00105417 ↗ |
| Known as | Interleukin-7 | “This study will evaluate whether interleukin-7 (IL-7) a drug similar to the natural IL-7 protein produced by the body, is safe to use in people infected with HIV.” NCT00105417 ↗ |
| Modality | Protein / enzyme biologic | “IL-7 a drug similar to the natural IL-7 protein produced by the body” NCT00105417 ↗ |
| Route | Subcutaneous | “The injections are given subcutaneously (under the skin)” NCT00105417 ↗ |